After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Jefferies analyst David Windley upgraded Humana to Buy as he continues to believe an acquisition by Aetna is likely, despite consensus and the market leaning in the opposite direction.
Oppenheimer analysts say Cigna's stock looks attractive at present levels.
Senate opponents' letter to the DOJ is unlikely to derail the merger following California's approval.
Concern that the $44 billion merger will not receive regulatory approval continues to grow.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.